BlackRock, Inc. 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Xeris Biopharma Holdings, Inc. XERS | BlackRock Inc. BLK | 1,684,166 2.500% | -1,963,052 (-53.82%) | Filing |
| 2021-02-01 08:30 am Purchase | 2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | BlackRock Inc. BLK | 3,647,218 7.400% | 1,450,471 (+66.03%) | Filing |